… use of biologic therapies include the use of biologic agents for moderate disease, and early
use of a biologic … strategies, support the use of biologics in the optimal management of RA. (J …

… Introduction The introduction of biologic therapy, and particularly the use of anti-tumor necrosis
factor alpha (TNF-a) therapy, has significantly changed the treatment and management of …

… In recent years the use of biologics has changed the management of IBD. The efficacy of
anti-TNFα molecules (infliximab, adalimumab and certolizumab pegol) has been largely …

… Although there is currently no cure for RA, the availability of new biologic treatments that
directly target components of the RA inflammatory cascade has transformed management of this …

… Biologic agents selectively interfere with the immune … trials of the biologic agents in the
treatment of psoriasis. … When selecting a biologic agent for use in a patient with psoriasis, one …

… their optimal thresholds, and to delineate the optimal … management ‘short-cuts’ will ultimately
lead to greater number of patients being treated with immune-modulators and/or biologics …

… necrosis factor antibodies remain the first-line biologic therapy in most areas of the world. …
in IBD management and also discuss potential strategies to optimize biologic treatment …

… The optimal administration of Bs is determined by treatment … Over the past three decades,
biologics (Bs) have been widely … biologic therapies has revolutionized the management of …

… management of IBD has changed substantially over the past decade since the introduction
of biologic … injections required to be given, the optimal time to screen for immunity and …

… size) between the biologics versus the phototherapy treatments … , such as volunteers for
biologic studies who may have been … optimal treatment options based on the best available data. …